Friday 11th February 2022 |
Text too small? |
Blis Technologies Limited announces the interim results (unaudited) for the third quarter ending 31 December 2021.
Revenue for Q3 FY22 was $2.3m, with an EBITDA loss of $0.4m. Q3 FY22 revenue was down $0.1m compared with the same period last year but has increased $0.2m over Q2 FY22. The trends evident in the half year result were also reflected in the third quarter result.
Compared with the same quarter last year, there was a 42% increase in finished product sales with growth in our BLIS webstore (which includes Skincare sales) and the launch into the Canadian market, which partially offset a decline in ingredient sales.
The Q3 FY22 EBITDA loss of $0.4m is in line with forecast and reflects further early investment in our key new market initiatives, the Canada and Skincare launches which represent important future growth drivers.
We reaffirm our existing market guidance of revenue between $8.6m and $9.1m with an EBITDA deficit in the range of $2.3m to $2.7m.
Please see the link below for details
Third quarter performance update
Source: Blis Technologies Limited
No comments yet
MPG - Metroglass clarifies media statements by Crescent Capital
VTL - Takeovers Panel orders Empire to reimburse Vital's expenses
March 14th Morning Report
SKT - Sky secures iconic sports rights
RYM - Ryman completes Retail Entitlement Offer
TEM - Transaction in Own Shares
FPH launches F&P Nova™ Nasal mask in NZ and AU
Fonterra announces changes to management team
March 12th Morning Report
WHS FY25 Interim Results teleconference details